Olema Pharmaceuticals Inc (NASDAQ: OLMA) is 1.03% higher on its value in year-to-date trading and has touched a low of $5.43 and a high of $16.77 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The OLMA stock was last observed hovering at around $5.57 in the last trading session, with the day’s gains setting it 0.32%.
Currently trading at $5.89, the stock is -15.86% and -36.16% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.33 million and changing 5.75% at the moment leaves the stock -47.20% off its SMA200. OLMA registered -56.18% loss for a year compared to 6-month loss of -44.80%. The firm has a 50-day simple moving average (SMA 50) of $9.2266 and a 200-day simple moving average (SMA200) of $11.15455.
The stock witnessed a -41.10% gain in the last 1 month and extending the period to 3 months gives it a -49.05%, and is -6.80% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.91% over the week and 10.10% over the month.
Olema Pharmaceuticals Inc (OLMA) has around 74 employees, a market worth around $356.87M and $0.00M in sales. Distance from 52-week low is 8.57% and -64.89% from its 52-week high. The company has generated returns on investments over the last 12 months (-61.50%).
The EPS is expected to shrink by -7.49% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Olema Pharmaceuticals Inc (OLMA) Top Institutional Holders
195.0 institutions hold shares in Olema Pharmaceuticals Inc (OLMA), with institutional investors hold 110.86% of the company’s shares. The shares outstanding are 57.29M, and float is at 42.88M with Short Float at 23.24%. Institutions hold 106.62% of the Float.
The top institutional shareholder in the company is BVF INC/IL with over 9.14 million shares valued at $98.85 million. The investor’s holdings represent 16.2322% of the OLMA Shares outstanding. As of 2024-06-30, the second largest holder is PARADIGM BIOCAPITAL ADVISORS LP with 7.9 million shares valued at $85.52 million to account for 14.0428 of the shares outstanding. The other top investors are DEEP TRACK CAPITAL, LP which holds 4.0 million shares representing 7.107% and valued at over $43.28 million, while BLACKROCK INC. holds 7.1062 of the shares totaling 4.0 million with a market value of $43.27 million.
Olema Pharmaceuticals Inc (OLMA) Insider Activity
The most recent transaction is an insider sale by Graham G. Walmsley, the company’s Director. SEC filings show that Graham G. Walmsley sold 700,761 shares of the company’s common stock on Dec 17 ’24 at a price of $6.75 per share for a total of $4.73 million. Following the sale, the insider now owns 0.0 shares.
Still, SEC filings show that on Dec 10 ’24, Harmon Cyrus (Director) disposed off 8,256 shares at an average price of $9.37 for $77359.0. The insider now directly holds 772,277 shares of Olema Pharmaceuticals Inc (OLMA).
